Safety, Tolerability and Efficacy of Microsomal Triglyceride Protein (MTP) Inhibitor

Clinical trial NCT01556906 · COMPLETED

Trial details

NCT number: NCT01556906
Sponsor: Aegerion Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Homozygous Familial Hypercholesterolemia

Start date: 2003-06-01
Primary completion: 2004-02-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.